The total synthesis of (+)-migrastatin

Journal of the American Chemical Society

Volumn 125, Issue 20, 2003, Pages 6042-6043

  Gaul, Christoph ^a   Njardarson, Jon T ^a   Danishefsky, Samuel J ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIGRASTATIN; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CHELATION; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; METHYLATION; POLYMERIZATION; RING CLOSING METATHESIS; STEREOCHEMISTRY; STREPTOMYCES; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS; LACTONES; MACROLIDES; PIPERIDONES; STEREOISOMERISM; STREPTOMYCES;

EID: 0038627700     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0349103     Document Type: Article

References (28)

1. (a) Nakae, K.; Yoshimoto, Y.; Sawa, T.; Homma, Y.; Hamada, M.; Takeuchi, T.; Imoto, M. J. Antibiot. 2000, 53, 1130.
2. (b) Nakae, K.; Yoshimoto, Y.; Ueda, M.; Sawa, T.; Takahashi, Y.; Naganawa, H.; Takeuchi, T.; Imoto, M. J. Antibiot. 2000, 53, 1228.
3. (c) Takemoto, Y.; Nakae, K.; Kawatani, M.; Takahashi, Y.; Naganawa, H.; Imoto, M. J. Antibiot. 2001, 54, 1104.
4. (d) Nakamura, H.; Takahashi, Y.; Naganawa, H.; Nakae, K.; Imoto, M.; Shiro, M.; Matsumura, K.; Watanabe, H.; Kitahara, T. J. Antibiot. 2002, 55, 442.
5. Woo, E. J.; Starks, C. M.; Carney, J. R.; Arslanian, R.; Cadapan, L.; Zavala, S.; Licari, P. J. Antibiot. 2002, 55, 141.
6. For selected reviews of angiogenesis-based cancer therapies, see: (a) Klagsbrun, M.; Moses, M. A. Chem. Biol. 1999, 6. R217. (b) Kerbel, R. S. Carcinogenesis 2000, 21, 505. (c) Deplanque, G.; Harris, A. L. Eur. J. Cancer 2000, 36, 1713. (d) Scappaticci, F. A. J. Clin. Oncol. 2002, 20, 3906.
7. For selected reviews of angiogenesis-based cancer therapies, see: (a) Klagsbrun, M.; Moses, M. A. Chem. Biol. 1999, 6. R217. (b) Kerbel, R. S. Carcinogenesis 2000, 21, 505. (c) Deplanque, G.; Harris, A. L. Eur. J. Cancer 2000, 36, 1713. (d) Scappaticci, F. A. J. Clin. Oncol. 2002, 20, 3906.
8. For selected reviews of angiogenesis-based cancer therapies, see: (a) Klagsbrun, M.; Moses, M. A. Chem. Biol. 1999, 6. R217. (b) Kerbel, R. S. Carcinogenesis 2000, 21, 505. (c) Deplanque, G.; Harris, A. L. Eur. J. Cancer 2000, 36, 1713. (d) Scappaticci, F. A. J. Clin. Oncol. 2002, 20, 3906.
9. For selected reviews of angiogenesis-based cancer therapies, see: (a) Klagsbrun, M.; Moses, M. A. Chem. Biol. 1999, 6. R217. (b) Kerbel, R. S. Carcinogenesis 2000, 21, 505. (c) Deplanque, G.; Harris, A. L. Eur. J. Cancer 2000, 36, 1713. (d) Scappaticci, F. A. J. Clin. Oncol. 2002, 20, 3906.
10. Gaul, C.; Danishefsky, S. J. Tetrahedron Lett. 2002, 43, 9039.
11. (a) Danishefsky, S. J. Aldrichimica Acta 1986, 19, 59.
12. (b) Danishefsky, S. J. Chemtracts 1989, 2, 273.
13. Jorgensen, M.; Iversen, E. H.; Paulsen, A. L.; Madsen, R. J. Org. Chem. 2001, 66, 4630.
14. Lee, W. W.; Chang, S. Tetrahedron: Asymmetry 1999, 10, 4473.
15. Danishefsky, S. J.; Yan, C. F.; Singh, R. K.; Gammill, R. B.; McCurry, P. M., Jr.; Fritsch, N.; Clardy, J. J. Am. Chem. Soc. 1979, 101, 7001.
16. Danishefsky, S. J.; Pearson, W. H.; Harvey, D. F.; Maring, C. J.; Springer, J. P. J. Am. Chem. Soc. 1985, 107, 1256.
17. Luche, J. L.; Gemal, A. L. J. Am. Chem. Soc. 1979, 101, 5848.
18. Ferrier, R. J. J. Chem. Soc. 1964, 5443.
19. Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2002, 124, 392.
20. Blanchette, M. A.; Choy, W.; Davis, J. T.; Essenfeld, A. M.; Masamune, S.; Roush, W. R.; Sakai, T. Tetrahedron Lett. 1984, 25, 2183.
21. Egawa, Y.; Suzuki, M.; Okuda, T. Chem. Pharm. Bull. 1963, 11, 589.
22. Mahoney, W. S.; Brestensky, D. M.; Stryker, J. M. J. Am. Chem. Soc. 1988, 110, 291.
23. Katzenellenbogen, J. A.; Crumrine, J. A. J. Am. Chem. Soc. 1976, 98, 4925.
24. Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 1989.
25. For a recent example, see: (b) Song, F.; Fidanze, S.; Benowitz, A. B.; Kishi, Y. Org. Lett. 2002, 4, 647.
26. (a) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953.
27. For one of the early applications of RCM in complex natural product synthesis, see: Xu, Z.; Johannes, C. W.; Salman, S. S.; Hoveyda, A. H. J. Am. Chem. Soc. 1996, 118, 10926.
28. Fully synthetic migrastatin was tested in a wound healing assay, and the results confirmed the findings of Imoto et al. for natural migrastatin.